dc.contributor.author |
Taher A.T. |
dc.contributor.author |
Musallam K.M. |
dc.contributor.author |
Inati A. |
dc.contributor.editor |
|
dc.date |
Dec-2009 |
dc.date.accessioned |
2017-10-05T15:41:08Z |
dc.date.available |
2017-10-05T15:41:08Z |
dc.date.issued |
2009 |
dc.identifier |
10.3109/03630260903346676 |
dc.identifier.isbn |
|
dc.identifier.issn |
03630269 |
dc.identifier.uri |
http://hdl.handle.net/10938/17847 |
dc.description.abstract |
In patients suffering from transfusion-dependent anemia, excess iron secondary to regular transfusions cannot be physiologically excreted. This leads to a state of chronic iron overload with iron accumulating in the liver, heart, and endocrine organs, and ultimately results in significant morbidity and mortality. Historically, iron overload was assessed through measurement of serum ferritin or direct determination of liver iron concentration (LIC) by means of biopsy. Although both correlate well with iron overload severity, several limitations pertinent to both are of concern. This has led to the identification of novel noninvasive iron assessment measures, namely magnetic resonance imaging (MRI) R2 and T2*. Moreover, investigations of other potential indices like nontransferrin-bound iron (NTBI) and labile plasma iron (LPI) are yielding promising results. Optimal iron overload assessment and monitoring is a key element in the development of improved strategies of iron chelation therapy that can be tailored to meet the patient's specific needs. © 2009 Informa UK, Ltd. |
dc.format.extent |
|
dc.language |
English |
dc.relation.ispartof |
Publication Name: Hemoglobin; Publication Year: 2009; Volume: 33; |
dc.relation.ispartofseries |
|
dc.relation.uri |
|
dc.source |
Scopus |
dc.subject.other |
|
dc.title |
Iron overload: Consequences, assessment, and monitoring |
dc.type |
Conference Paper |
dc.contributor.affiliation |
Taher, A.T., Department of Internal Medicine, American University, Beirut Medical Center, P.O. Box: 110236, Riad El-Solh 1107 2020, Beirut, Lebanon, Chronic Care Center, Hazmieh, Lebanon |
dc.contributor.affiliation |
Musallam, K.M., Department of Internal Medicine, American University, Beirut Medical Center, P.O. Box: 110236, Riad El-Solh 1107 2020, Beirut, Lebanon |
dc.contributor.affiliation |
Inati, A., Chronic Care Center, Hazmieh, Lebanon, Division of Pediatric Hematology and Oncology, Children's Center for Cancer and Blood Diseases, Rafik Hariri University Hospital, Beirut, Lebanon |
dc.contributor.authorAddress |
Taher, A. T.; Department of Internal Medicine, American University, Beirut Medical Center, P.O. Box: 110236, Riad El-Solh 1107 2020, Beirut, Lebanon; email: ataher@aub.edu.lb |
dc.contributor.authorCorporate |
University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Internal Medicine; |
dc.contributor.authorDepartment |
Internal Medicine |
dc.contributor.authorDivision |
|
dc.contributor.authorEmail |
|
dc.contributor.faculty |
Faculty of Medicine |
dc.contributor.authorInitials |
|
dc.contributor.authorOrcidID |
|
dc.contributor.authorReprintAddress |
|
dc.contributor.authorResearcherID |
|
dc.contributor.authorUniversity |
American University of Beirut Medical Center |
dc.description.cited |
|
dc.description.citedCount |
26 |
dc.description.citedTotWOSCount |
|
dc.description.citedWOSCount |
|
dc.format.extentCount |
|
dc.identifier.articleNo |
|
dc.identifier.coden |
HEMOD |
dc.identifier.pubmedID |
20001632 |
dc.identifier.scopusID |
73949096220 |
dc.identifier.url |
|
dc.publisher.address |
|
dc.relation.ispartofConference |
|
dc.relation.ispartofConferenceCode |
|
dc.relation.ispartofConferenceDate |
|
dc.relation.ispartofConferenceHosting |
|
dc.relation.ispartofConferenceLoc |
|
dc.relation.ispartofConferenceSponsor |
|
dc.relation.ispartofConferenceTitle |
|
dc.relation.ispartofFundingAgency |
|
dc.relation.ispartOfISOAbbr |
|
dc.relation.ispartOfIssue |
|
dc.relation.ispartOfPart |
|
dc.relation.ispartofPubTitle |
Hemoglobin |
dc.relation.ispartofPubTitleAbbr |
Hemoglobin |
dc.relation.ispartOfSpecialIssue |
|
dc.relation.ispartOfSuppl |
|
dc.relation.ispartOfVolume |
33 |
dc.source.ID |
|
dc.type.publication |
Series |
dc.subject.otherAuthKeyword |
Diagnosis |
dc.subject.otherAuthKeyword |
Endocrine |
dc.subject.otherAuthKeyword |
Heart |
dc.subject.otherAuthKeyword |
Iron overload |
dc.subject.otherAuthKeyword |
Liver |
dc.subject.otherAuthKeyword |
Review |
dc.subject.otherChemCAS |
deferoxamine, 70-51-9 |
dc.subject.otherChemCAS |
ferritin, 9007-73-2 |
dc.subject.otherChemCAS |
iron, 14093-02-8, 53858-86-9, 7439-89-6 |
dc.subject.otherChemCAS |
transferrin, 82030-93-1 |
dc.subject.otherChemCAS |
Iron, 7439-89-6 |
dc.subject.otherIndex |
deferoxamine |
dc.subject.otherIndex |
ferritin |
dc.subject.otherIndex |
iron |
dc.subject.otherIndex |
transferrin |
dc.subject.otherIndex |
anemia |
dc.subject.otherIndex |
arthropathy |
dc.subject.otherIndex |
blood transfusion |
dc.subject.otherIndex |
carcinogenesis |
dc.subject.otherIndex |
chelation therapy |
dc.subject.otherIndex |
conference paper |
dc.subject.otherIndex |
degenerative disease |
dc.subject.otherIndex |
disease severity |
dc.subject.otherIndex |
endocrine disease |
dc.subject.otherIndex |
endocrine gland |
dc.subject.otherIndex |
ferritin blood level |
dc.subject.otherIndex |
heart |
dc.subject.otherIndex |
heart disease |
dc.subject.otherIndex |
heart function |
dc.subject.otherIndex |
heart left ventricle ejection fraction |
dc.subject.otherIndex |
human |
dc.subject.otherIndex |
hyperpigmentation |
dc.subject.otherIndex |
iron chelation |
dc.subject.otherIndex |
iron overload |
dc.subject.otherIndex |
liver |
dc.subject.otherIndex |
liver biopsy |
dc.subject.otherIndex |
liver cirrhosis |
dc.subject.otherIndex |
liver fibrosis |
dc.subject.otherIndex |
liver injury |
dc.subject.otherIndex |
monitoring |
dc.subject.otherIndex |
morbidity |
dc.subject.otherIndex |
mortality |
dc.subject.otherIndex |
nuclear magnetic resonance imaging |
dc.subject.otherIndex |
pulmonary hypertension |
dc.subject.otherIndex |
thalassemia |
dc.subject.otherIndex |
Chelation Therapy |
dc.subject.otherIndex |
Humans |
dc.subject.otherIndex |
Iron |
dc.subject.otherIndex |
Iron Overload |
dc.subject.otherIndex |
Magnetic Resonance Imaging |
dc.subject.otherIndex |
Tissue Distribution |
dc.subject.otherKeywordPlus |
|
dc.subject.otherWOS |
|